MassBiologics grants licensing agreement to Merck for tetanus-diphtheria vaccineBOSTON A biotech developer owned by the University of Massachusetts Medical School has granted drug maker Merck exclusive U.S. rights to its tetanus and diphtheria vaccine, Merck announced Wednesday. Sagent’s metoprolol tartrate receives FDA approval Ohr moves its headquarters CVS Caremark: Patients believe specialty pharmacy team encourages medication adherence IMS Health projects global pharmaceutical market to grow nearly $300 billion by 2014 Sagent gets approval for generic bladder inflammation treatment Matrix Labs' Videx EC generic approved by FDA FDA approves expanded use of Tarceva Analyst upgrades AmerisourceBergen, deems company top drug distributor Shelf life of Privigen extended First Previous 199 200 201 202 203 Next Last
